BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8037458)

  • 1. The post-translational processing of myeloperoxidase is regulated by the availability of heme.
    Pinnix IB; Guzman GS; Bonkovsky HL; Zaki SR; Kinkade JM
    Arch Biochem Biophys; 1994 Aug; 312(2):447-58. PubMed ID: 8037458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural, immunochemical, and cytochemical study of myeloperoxidase in myeloid leukemia HL-60 cells following treatment with succinylacetone, an inhibitor of heme biosynthesis.
    CastaƱeda VL; Parmley RT; Pinnix IB; Raju SG; Guzman GS; Kinkade JM
    Exp Hematol; 1992 Aug; 20(7):916-24. PubMed ID: 1321053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of heme insertion and the mannose-6-phosphate receptor in processing of the human myeloid lysosomal enzyme, myeloperoxidase.
    Nauseef WM; McCormick S; Yi H
    Blood; 1992 Nov; 80(10):2622-33. PubMed ID: 1330078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis and sorting of myeloperoxidase in hematopoietic cells.
    Olsson I; Bulow E; Hansson M
    Jpn J Infect Dis; 2004 Oct; 57(5):S13-4. PubMed ID: 15507754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased mutant frequencies in the HPRT gene locus of leukemia HL-60 cells treated with succinylacetone.
    Zheng KC; Yalowich JC; Kagan VE; Keohavong P
    Cell Biol Toxicol; 2006 Sep; 22(5):361-70. PubMed ID: 16838078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational control of erythroid delta-aminolevulinate synthase in immature human erythroid cells by heme.
    Smith SJ; Cox TM
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):103-14. PubMed ID: 9074795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of gene expression of myeloperoxidase during myeloid differentiation.
    Tobler A; Miller CW; Johnson KR; Selsted ME; Rovera G; Koeffler HP
    J Cell Physiol; 1988 Aug; 136(2):215-25. PubMed ID: 2842344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and ultrastructural effects of monensin on the processing, intracellular transport, and packaging of myeloperoxidase into low and high density compartments of human leukemia (HL-60) cells.
    Akin DT; Kinkade JM; Parmley RT
    Arch Biochem Biophys; 1987 Sep; 257(2):451-63. PubMed ID: 2821913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting myeloperoxidase to azurophilic granules in HL-60 cells.
    Lemansky P; Gerecitano-Schmidek M; Das RC; Schmidt B; Hasilik A
    J Leukoc Biol; 2003 Oct; 74(4):542-50. PubMed ID: 12960244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of heme synthesis in bone marrow cells by succinylacetone: effect on globin synthesis.
    Beru N; Sahr K; Goldwasser E
    J Cell Biochem; 1983; 21(2):93-105. PubMed ID: 6193131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthesis and processing of myeloperoxidase--a marker for myeloid cell differentiation.
    Nauseef WM; Olsson I; Arnljots K
    Eur J Haematol; 1988 Feb; 40(2):97-110. PubMed ID: 2831080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of haem biosynthesis inhibitors and inducers on intestinal iron absorption and liver haem biosynthetic enzyme activities.
    Laftah AH; Simpson RJ; Peters TJ; Raja KB
    Toxicol Appl Pharmacol; 2008 Jun; 229(3):273-80. PubMed ID: 18384829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase is a key regulator of oxidative stress mediated apoptosis in myeloid leukemic cells.
    Nakazato T; Sagawa M; Yamato K; Xian M; Yamamoto T; Suematsu M; Ikeda Y; Kizaki M
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5436-45. PubMed ID: 17875773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of hematoporphyrin uptake and in vitro-growth inhibition of L1210 leukemia cells by succinylacetone.
    Ebert PS; Hess RA; Tschudy DP
    J Natl Cancer Inst; 1985 Mar; 74(3):603-8. PubMed ID: 3856064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of iron in reticulocytes after inhibition of heme synthesis with succinylacetone: examination of the intermediates involved in iron metabolism.
    Richardson DR; Ponka P; Vyoral D
    Blood; 1996 Apr; 87(8):3477-88. PubMed ID: 8605367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Succinylacetone inhibits delta-aminolevulinate dehydratase and potentiates the drug and steroid induction of delta-aminolevulinate synthase in liver.
    Sassa S; Kappas A
    Trans Assoc Am Physicians; 1982; 95():42-52. PubMed ID: 7182986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of hemoglobin synthesis in erythroid differentiating K562 cells. I. Role of iron in erythroid cell heme synthesis.
    Kawasaki N; Morimoto K; Tanimoto T; Hayakawa T
    Arch Biochem Biophys; 1996 Apr; 328(2):289-94. PubMed ID: 8645006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferrochelatase, glutathione peroxidase and transferrin receptor mRNA synthesis and levels in mouse erythroleukemia cells.
    Fuchs O
    Stem Cells; 1993 May; 11 Suppl 1():13-23. PubMed ID: 8318915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.
    Sassa S; Kappas A
    J Clin Invest; 1983 Mar; 71(3):625-34. PubMed ID: 6826727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.